Behaviour disorders occur frequently in institutionalized mentally retarded pa tients. Abnormal behaviour which is severe enough to interfere with the normal functioning of ward, school and occupational therapy, requires treatment. With the advent of the phenothiazines, more effective treatment of behavioural disturbances and problems of an emo tional nature became possible. The phenothiazine which has been extensively employed during the past four years in our Hospital School is thioridazine**. The drug has been selected because it possesses a broad spectrum of clinical application and has been shown to be as effective as the best of the phenothiazines (6, 4) . In addition, its diminished incidence of ex trapyramidal effects and lack of bone marrow toxicity are distinct advantages (5) . Considering the necessary reliance on chemotherapy we decided to re evaluate the effectiveness of thioridazine in our patient population.
Material and Method
All mentally deficient patients who had received thioridazine for a period from four months to four years were in cluded in the evaluation. The total pa tient population -304 patients -was divided into two groups, A and B. Group A consisted of 236 patients, all free of convulsive disorders. Group B consisted of 68 patients with convulsive disorders who were receiving thiori dazine in combination with anticonvul sant medication. The average age of the The patient's status concerning be havioural and emotional symptoms prior to and during thioridazine administration was reviewed and registered on special evaluation charts. Dosage adjustments were made if required and a final evalua tion followed, usually two to three months later when the patient was con sidered to be on a maximum therapeutic dosage of thioridazine. The patient's final evaluation was compared to pre-drug status and evaluated in accordance with a five-point rating scale: 1) worse, 2) no improvement, 3) fair improvementsymptoms attenuated by 40-60% and the patient became more manageable within the ward, 4) good improvement -symp toms became attenuated by 60-80% and the patient was able to pursue his daily activities, and 5) very good improve ment -symptoms became attenuated by 80-100% and the patient no longer need ed close supervision.
Results
The over-all results for Group A and B are shown in Table I . In addition we related the results to different age groups and I.Q. levels. No significant difference, however, was observed, i.e. a young patient improved as well as an older patient, or a patient with a low I.Q. improved as well as a patient with a comparatively high I.Q. Further analysis of the results indicated a slightly better improvement rating in favour of the male population as compared to the female population. This difference, how ever, did not reach a statistically signi ficant level. Thirty-nine different target symptoms which required medication could be denned among the patients in Group A. Table II shows the ten most frequent symptoms, their incidence and percen tage of good and very good improve ment. Other important symptoms which responded favourably to thioridazine but were not as frequently observed, were abnormal sexual behaviour where 79.4% improvement was obtained, enuresis -82.1% improvement, depression -92.0% improvement and distractability -77.4% improvement.
Among the patients in Group B twenty-nine different target symptoms could be defined. The five most preva lent symptoms, their incidence and the effect of thioridazine are tabulated in Table III .
Of special interest to us in treating this group of patients was the effect of thioridazine on seizure patterns. The seizure pattern did not increase for any of our 68 patients under observation. On the contrary, the frequency of seizures was markedly decreased for 60 (88.2%) of the patients.
The incidence of side effects in both patient populations was extremely low. Drowsiness occurred occasionally, but usually subsided after a few days or after decreasing dosage. During our fouryears' experience with thioridazine we never encountered photosensitivity, jaun dice, or blood dyscrasias.
Comments
The results obtained with thioridazine are very gratifying. Our experience indi cates a broad therapeutic spectrum for this drug. As with other psychoactive agents the dosages employed bad to be individualized. The dosage ranged from The over-all effect of thioridazine which was observed in our patients could be called an 'ego stablizing effect'. Not only did the patients' abnormal behaviour and emotional patterns correct them selves, but also the whole personality of the mentally retarded patients appeared to get better organized. We also ob served what Abbott, et al (1) calls the carry-over effect from the aggressive to less affected patients sharing the same ward.
Special psychiatric problems among mentally retarded patients are being re cognized more and more. It is almost impossible to draw a line between emo tional or neurologically triggered upsets. It is an encouraging experience, however, to see how chemotherapy, in our case thioridazine, was able to free even the patients functioning at the idiot level of intelligence from 'neurological im prisonment' into a more mature and co ordinated behaviour pattern.
